These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. US State Public Health Departments Special Pathogen Planning. Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ J Public Health Manag Pract; 2018; 24(5):E28-E33. PubMed ID: 29227420 [TBL] [Abstract][Full Text] [Related]
3. High-Level Isolation Unit Infection Control Procedures. Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ Health Secur; 2017; 15(5):519-526. PubMed ID: 29058966 [TBL] [Abstract][Full Text] [Related]
4. Capabilities of global high-level isolation units: A pre-workshop survey. Herstein JJ; Wolf T; Nicastri E; Leo YS; Lim PL; Jacobs M; Vanairsdale S; Toner E; Shearer MP; Vasa A; Mukherjee V; Echeverri A; Shenoy ES; Lowe JJ Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1679-1685. PubMed ID: 34847983 [TBL] [Abstract][Full Text] [Related]
5. Personnel Management and Biosecurity of U.S. High-Level Isolation Units. Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ J Nurs Adm; 2018 Nov; 48(11):553-560. PubMed ID: 33216517 [TBL] [Abstract][Full Text] [Related]
6. Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers. Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ Emerg Infect Dis; 2017 Jun; 23(6):965-967. PubMed ID: 28518036 [TBL] [Abstract][Full Text] [Related]
8. EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey. Fusco FM; Schilling S; Puro V; Brodt HR; Follin P; Jarhall B; Bannister B; Maltezou HC; Thomson G; Brouqui P; Ippolito G; Clin Microbiol Infect; 2009 Aug; 15(8):711-9. PubMed ID: 19486074 [TBL] [Abstract][Full Text] [Related]
9. Current Capabilities and Capacity of Ebola Treatment Centers in the United States. Herstein JJ; Biddinger PD; Kraft CS; Saiman L; Gibbs SG; Le AB; Smith PW; Hewlett AL; Lowe JJ Infect Control Hosp Epidemiol; 2016 Mar; 37(3):313-8. PubMed ID: 26641267 [TBL] [Abstract][Full Text] [Related]
10. The Creation of a Biocontainment Unit at a Tertiary Care Hospital. The Johns Hopkins Medicine Experience. Garibaldi BT; Kelen GD; Brower RG; Bova G; Ernst N; Reimers M; Langlotz R; Gimburg A; Iati M; Smith C; MacConnell S; James H; Lewin JJ; Trexler P; Black MA; Lynch C; Clarke W; Marzinke MA; Sokoll LJ; Carroll KC; Parish NM; Dionne K; Biddison EL; Gwon HS; Sauer L; Hill P; Newton SM; Garrett MR; Miller RG; Perl TM; Maragakis LL Ann Am Thorac Soc; 2016 May; 13(5):600-8. PubMed ID: 27057583 [TBL] [Abstract][Full Text] [Related]
11. Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Bannister B; Puro V; Fusco FM; Heptonstall J; Ippolito G; Lancet Infect Dis; 2009 Jan; 9(1):45-56. PubMed ID: 19095195 [TBL] [Abstract][Full Text] [Related]
12. Hazardous materials management and control in clinical laboratories of small hospitals. Linde MK Clin Lab Manage Rev; 1993; 7(6):493-4, 496-9. PubMed ID: 10171750 [TBL] [Abstract][Full Text] [Related]
13. Use, location, and timeliness of clinical microbiology testing in Georgia for select infectious diseases. Brzozowski AK; Silk BJ; Berkelman RL; Loveys DA; Caliendo AM J Public Health Manag Pract; 2012; 18(4):E4-E10. PubMed ID: 22635201 [TBL] [Abstract][Full Text] [Related]
14. The utility and sustainability of US Ebola treatment centers during the coronavirus disease 2019 (COVID-19) pandemic. Herstein JJ; Biddinger PD; Gibbs SG; Hewlett AL; Le AB; Schwedhelm MM; Lowe JJ Infect Control Hosp Epidemiol; 2023 Apr; 44(4):643-650. PubMed ID: 35189995 [TBL] [Abstract][Full Text] [Related]
15. Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing. Fed Regist; 1997 Oct; 62(201):54160-308. PubMed ID: 10177300 [TBL] [Abstract][Full Text] [Related]
16. Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come. Kortepeter MG; Kwon EH; Hewlett AL; Smith PW; Cieslak TJ J Infect Dis; 2016 Oct; 214(suppl 3):S137-S141. PubMed ID: 27651413 [TBL] [Abstract][Full Text] [Related]
17. Deployment of the 1st Area Medical Laboratory in a Split-Based Configuration During the Largest Ebola Outbreak in History. Cardile AP; Littell CT; Backlund MG; Heipertz RA; Brammer JA; Palmer SM; Vento TJ; Ortiz FA; Rosa WR; Major MJ; Garman PM Mil Med; 2016 Nov; 181(11):e1675-e1684. PubMed ID: 27849507 [TBL] [Abstract][Full Text] [Related]
18. U.S. Medical Examiner/Coroner capability to handle highly infectious decedents. Le AB; Brooks EG; McNulty LA; Gill JR; Herstein JJ; Rios J; Patlovich SJ; Jelden KC; Schmid KK; Lowe JJ; Gibbs SG Forensic Sci Med Pathol; 2019 Mar; 15(1):31-40. PubMed ID: 30402743 [TBL] [Abstract][Full Text] [Related]
19. Survey of Sexually Transmitted Disease Laboratory Methods in U.S. Army Laboratories, 2012. Leamer NK; Jordan NN; Pacha LA; Latif NH; Garges EC; Gaydos JC Mil Med; 2017 Mar; 182(3):e1726-e1732. PubMed ID: 28290950 [TBL] [Abstract][Full Text] [Related]